Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05949008 · ClinicalTrials.gov registry record · Phase 4

Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo

A Phase 4 study of Obesity and NIDDM, sponsored by University of California, Los Angeles.

Active
Registry status
Phase 4
Development phase
150
Enrollment target
1
Study location

NCT05949008 is a Phase 4 study of Obesity and NIDDM that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 150 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05949008, a Phase 4 study of Obesity and NIDDM, is active but no longer recruiting, sponsored by University of California, Los Angeles.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

Metformin is a drug used to treat patients with diabetes. The aim of this study is to examine the effect of Metformin along with a low-calorie diet on obese and/or overweight adults with an increased waist measurement. In addition, the study also aims to look at the effect of the drug vs. placebo on quality of life and physical activity.

Conditions Studied

Obesity NIDDM

Interventions

  • DRUG Placebo
  • DRUG Metformin Extended Release (ER) Oral Tablet

Study Locations (1)

California

  • UCLA Center for Human Nutrition - Los Angeles

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-11-22
Est. Completion 2027-07-30
Phase Phase 4

Sponsor

University of California, Los Angeles

897 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05949008

The ClinicalTrials.gov registry entry for NCT05949008 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05949008 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05949008 about?

NCT05949008 is a clinical study titled "Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo". Metformin is a drug used to treat patients with diabetes. The aim of this study is to examine the effect of Metformin along with a low-calorie diet on obese and/or overweight adults with an increased waist measurement. In addition, the study also aims to look at the effect of the drug vs. placebo on...

What is the current status of trial NCT05949008?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2023-11-22. Estimated completion is 2027-07-30.

What conditions does trial NCT05949008 study?

This clinical trial studies the following conditions: Obesity, NIDDM.

What interventions are being tested in trial NCT05949008?

The interventions under investigation include: Placebo (DRUG), Metformin Extended Release (ER) Oral Tablet (DRUG).

Who is sponsoring clinical trial NCT05949008?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05949008 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

NIDDM

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.